profit from every $100 of sales.
$0$100
PMGC Holdings
$1.58-6.51% today
-98.9% in 1 year
1-year low $1.581-year high $140.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What PMGC Holdings sold, what it kept, and what it did with the cash.
Sales went from $766,277 in 2022 to $590,084 in 2025, with -$7.75 million of profit last year.
SalesProfit
PMGC Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| PMGC Holdings | No profit yet | ||
 Vertex Pharmaceuticals | 35.1× · Expensive | ||
 Moderna | No profit yet | ||
 Regeneron Pharmaceuticals | 22.0× · Fair price | ||
 CSL | 22.1× · Fair price |
AI analysis
An AI analyst reads PMGC Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 0 | 0 | 1 | |
| 0 | 1 | 0 | 0 | |
| -2 | -1 | -4 | -7 | |
| -2 | -2 | -3 | -7 | |
| -2 | -4 | -6 | -8 | |
| -12,246.72 | -29,262.02 | -1,195.13 | -380.99 | |
| 58.4% | – | – | 31.4% | |
| -233.4% | – | – | -1,156.0% | |
| -234.9% | – | – | -1,313.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2 | 5 | 9 | 13 |
| Cash | 1 | 3 | 4 | 5 |
| Total debt | 0 | 0 | 0 | 3 |
| Total liabilities | 1 | 1 | 2 | 5 |
| 1 | 4 | 7 | 8 | |
| 0 | 0 | 0 | 0 | |
| -100.4% | -32.4% | -38.9% | -56.5% | |
| -159.1% | -112.4% | -93.8% | -98.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2 | -5 | -5 | -6 | |
| 0 | 0 | 0 | 0 | |
| -2 | -5 | -6 | -6 | |
| Dividends paid | – | – | – | – |
| – | – | 0 | 0 | |
| 0 | 0 | 0 | -0 |
Valuation
- –
- –
- –
- 0.0×
- 2.2×
- –
- –
- -498.9%
- -605.7%
- 0.0%
Profitability
- 31.4%
- -1,156.0%
- -1,313.0%
- -306.3%
- -305.8%
- -115.1%
- -88.2%
- -249.8%
- -323.1%
- 6.9%
Growth
- −8.3%
- –
- −16.3%
- –
- −34.8%
Financial health
- -0.4×
- 0.06
- 4.5%
- -11.5×
- 3.91
- 2.90
- 0.77
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 9%of 889
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -11.21 | – | – |
| Mar 26, 2026 | -0.52 | – | – |
| Nov 14, 2025 | -19.80 | – | – |
| Aug 12, 2025 | -6.44 | – | – |
| May 14, 2025 | -40.60 | – | – |
| Apr 4, 2025 | -99.99 | – | – |
| Nov 13, 2024 | -1,371.66 | – | – |
| Aug 14, 2024 | -1,567.61 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/6Passes 1 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
78Pass
Philip Fisher
42No pass
Peter Lynch
39No pass
Joel Greenblatt
–Not enough data
Charlie Munger
45No pass
Terry Smith
34No pass
Questions about PMGC Holdings
Is PMGC Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PMGC Holdings AI analysis
What does PMGC Holdings do?
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. It is in Biotechnology.
Does PMGC Holdings pay a dividend?
No. PMGC Holdings does not pay a dividend at the moment; in 2025 it returned $179 to shareholders by buying back its own shares.
Is PMGC Holdings stock halal?
No. PMGC Holdings does not pass our halal screen: its debt is 207% of its market value, at or above the 33% limit. How we check
How has PMGC Holdings stock done over the past year?
Down 98.9% over the past twelve months, to $1.58. It traded between $1.58 and $140.00 and is 98.9% below its high.
Who are PMGC Holdings's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals and CSL. The peers table on this page compares their profit, growth and price with PMGC Holdings's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.